Abstract | BACKGROUND: OBJECTIVES: This article reviews the basic pharmacology, as well as efficacy and safety data of selegiline transdermal system for the treatment of depression. CONCLUSIONS:
|
Authors | Jayasree J Nandagopal, Melissa P DelBello |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 10
Issue 10
Pg. 1665-73
(Jul 2009)
ISSN: 1744-7666 [Electronic] England |
PMID | 19527191
(Publication Type: Journal Article, Review)
|
Chemical References |
- AN-1792
- Amyloid beta-Peptides
- Selegiline
|
Topics |
- Administration, Cutaneous
- Amyloid beta-Peptides
(administration & dosage, adverse effects, therapeutic use)
- Animals
- Clinical Trials as Topic
- Depressive Disorder, Major
(drug therapy, metabolism)
- Humans
- Randomized Controlled Trials as Topic
- Selegiline
(administration & dosage, adverse effects, therapeutic use)
- Treatment Outcome
|